Lyso-globotetraosylceramide (d18:1)

Formulation: A solid

Formal Name: N-((2S,3R,4R,5R,6R)-2-(((2R,3R,4S,5S,6R)-2-(((2R,3R,4R,5R,6S)-6-(((2R,3S,4R,5R,6R)-6-(((2S,3R,E)-2-amino-3-hydroxyoctadec-4-en-1-yl)oxy)-4,5-dihydroxy-2-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-4,5-dihydroxy-2-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)acetamide

Purity: ≥98%

Formula Markup: C44H80N2O22

Formula Weight: 989,1

Shelf life (days): 730

Notes: Lyso-globotetraosylceramide is a form of globotetraosylceramide (Gb4) lacking the fatty acyl group. It binds to the Shiga-like toxin pig verotoxin of edema disease (VTE) in a glycolipid binding assay.{45542} Lyso-globotetraosylceramide is acylated to stearic acid (Item No. 10011298) via a condensation reaction mediated by sphingolipid ceramide N-deacylase to form a ceramide.{45543} As this product is derived from a natural source, there may be variations in the sphingoid backbone. [Matreya, LLC. Catalog No. 1541]

• Artikelnummer: CAY29134
• Hersteller: Cayman Chemical
• Hersteller Artikelnummer: 29134-1
• Green Labware: Nein
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK